Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
International Journal of Radiation Oncology, Biology, Physics|March 6, 2004
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancerAlbert C Koong, Quynh T Le, Anthony Ho, et al.Haematologica|September 2, 2004
Sequential administration of gemtuzumab ozogamicin and conventional chemotherapy as first line therapy in elderly patients with acute myeloid leukemia: a phase II study (AML-15) of the EORTC and GIMEMA leukemia groupsSergio Amadori, Stefan Suciu, Roel Willemze, et al.International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care|March 15, 2008
Detection and prevention of medication misadventures in general practiceKa Wae Tammy Tam, Kon Hung Kwok, Yuen Man Cecilia Fan, et al.Scientific Reports|November 25, 2025
Complex genotype-phenotype relationships shape the response to treatment of down syndrome childhood acute lymphoblastic leukaemiaChristoph Lutz, Virginia A Turati, Ruth Clifford, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyMarkus Schaich, Christoph Röllig, Silke Soucek, et al.Lancet (London, England)|August 11, 2012
Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised studyHannes Wandt, Kerstin Schaefer-Eckart, Knut Wendelin, et al.Nature Genetics|May 28, 2024
Cell-type-specific consequences of mosaic structural variants in hematopoietic stem and progenitor cellsKaren Grimes, Hyobin Jeong, Amanda Amoah, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 18, 2010
Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trialHans Theodor Eich, Volker Diehl, Helen Görgen, et al.Seminars in Radiation Oncology|March 23, 2016
Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic RadiosurgerySusan M Hiniker, Leslie A Modlin, Clara Y Choi, et al.The Lancet. Oncology|January 30, 2008
Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)Michael Pfreundschuh, Joerg Schubert, Marita Ziepert, et al.Pageof 7